Sunbeam Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$951K Buy
7,398
+67
+0.9% +$7.84K 0.43% 48
2026
Q1
$882K Buy
7,331
+232
+3% +$26.8K 0.5% 40
2025
Q4
$747K Buy
7,099
+94
+1% +$8.82K 0.44% 46
2025
Q3
$594K Buy
7,005
+43
+0.6% +$3.54K 0.37% 49
2025
Q2
$557K Buy
6,962
+762
+12% +$60.6K 0.42% 45
2025
Q1
$561K Buy
6,200
+34
+0.6% +$3.17K 0.53% 35
2024
Q4
$613K Buy
+6,166
New +$636K 0.57% 34

Other funds holding MRK

Sunbeam Capital Management's MRK Position: Q2 2026 in Review

Sunbeam Capital Management increased its Merck (MRK) stake by 0.91% in Q2 2026, buying an estimated $7.84K and bringing the position to 7,398 shares worth $951K. The position accounts for 0.43% of the portfolio, ranked #48.

Sunbeam Capital Management first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 1,865 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Sunbeam Capital Management held 7,398 shares of Merck worth $951K as of Q2 2026.
  • Sunbeam Capital Management bought 67 Merck shares in Q2 2026, an estimated $7.84K.
  • Merck made up 0.43% of Sunbeam Capital Management's portfolio in Q2 2026, its #48 holding.
  • Sunbeam Capital Management first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 1,865 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Sunbeam Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.